Skip to main content
SpringerLink
Log in

Gastrointestinal cytoprotective effects of misoprostol

Clinical efficacy overview

  • Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The cytoprotective effects of misoprostol, a synthetic analog of prostaglandin E1, were investigated in healthy human subjects using randomized and placebo-controlled studies. Misoprostol significantly inhibited established aspirin (975 mg q.i.d.)-induced gastric microbleeding at 50 μg q.i.d., and to some extent, but not significantly, at 25 μg q.i.d. Misoprostol also reduced acid and chloride secretion significantly at 50 μg q.i.d., but not at 25 μg q.i.d. When administered concurrently with aspirin 650 mg q.i.d., misoprostol 25 μg q.i.d. significantly inhibited aspirin-induced fecal blood loss without affecting plasma salicylate concentration. The fact that misoprostol was tested at a sub-therapeutic gastric antisecretory dose (25 μg) indicates that the inhibition of fecal blood loss was not due to its gastric antisecretory property. Misoprostol tended to reduce antral erosion and DNA content of gastric fluid, but increased mucus concentrations in subjects with ethanol-induced damage. However, the dose of ethanol used produced gastric damage in only six of the 10 subjects and did not provide a satisfactory baseline. Misoprostol attenuated the drop in transmucosal potential difference induced by sodium taurocholate. It is concluded that misoprostol has cytoprotective activity in man. These effects may be of great importance in the treatment of acid peptic disease of the gastrointestinal tract.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chaudhury TK, Jacobson ED: Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74:59–63, 1978

    Google Scholar 

  2. Miller TA, Jacobson ED: Gastrointestinal cytoprotection by prostaglandins. Gut 20:75–87, 1979

    Google Scholar 

  3. Robert A, Nezamis J, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats: Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433–443, 1979

    Google Scholar 

  4. Guth PH, Aures D, Paulsen G: Topical aspirin plus HCl induce gastric lesions in the rat; cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology 76:88, 1979

    Google Scholar 

  5. Dajani EZ, Callison DA, Bertermann RE: Effects of Eprostaglandins on canine gastric potential difference. Dig Dis Sci 23:436–442, 1978

    Google Scholar 

  6. Colton DG, Callison DA, Dajani EZ: Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther 210:283–288, 1970

    Google Scholar 

  7. Colton DG, Driskill DR, Phillips EL, Poy P, Dajani EZ: Effect of SC-29333, an inhibitor of gastric secretion on canine gastric mucosal blood flow and serum gastrin levels. Arch Int Pharmacodyn Ther 236:86–95, 1978

    Google Scholar 

  8. Larsen KR, Jensen NF, David EK, Jensen JC, Moody FG: The cytoprotective effects of (±) 15-deoxy-16-alpha, betahydroxy-16-methyl PGE1 methyl ester (SC-29333) versus aspirin-shock gastric ulcerogenesis in the dog. Prostaglandins 21 (Suppl):119–124, 1981

    Google Scholar 

  9. Cohen MM: Mucosal cytoprotection by prostaglandin E2 Lancet 2:1253–1254, 1978

    Google Scholar 

  10. Johansson C, Kollberg B, Nordemar R, Samuelson K, Bergstrom S: Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases. Gastroenterology 78:479–483, 1980

    Google Scholar 

  11. Tarnawski A, Stachura J, Ivey KJ, Mach T, Bogdal J, Klimczyk B: Ethanol-induced duodenal lesions in man. Protective effect of prostaglandin. Prostaglandins 21 (Suppl):147–154, 1981

    Google Scholar 

  12. Bauer RF: Misoprostol (SC-29333) preclinical pharmacological studies, unpublished document, G. D. Searle & Co. BRD 83D 1219, March, 1983

  13. Hunt JN, Smith JL, Jiang CL, Kessler L: Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion. Dig Dis Sci 28(10):897–902, 1983

    Google Scholar 

  14. Cohen MM, Clark L, Armstrong L, D'Souza J: Reduced aspirin-induced fecal blood loss with simutaneous administration of misoprostol (PGE1 methyl analogue). Gastroenterology 84:1126 (Abstract), 1983

    Google Scholar 

  15. Wilson DE: Cytoprotection against gastroduodenal damage. Drug Ther 13(7):87–93, 1983

    Google Scholar 

  16. Fimmel CJ, Blum AL: Acid inhibition, but no protection from bile salt damage by a prostaglandin E1 analogue in man. Gastroenterology 84 (5, Part 2):1151 (Abstract), 1983

    Google Scholar 

  17. Fimmel CJ, Blum AL: Failure of SC-29333, a PGE1 analog to protect the human stomach from bile-induced damage. Abstract presented at an “International Conference on Mechanisms of Mucosal Protection in Upper Gastrointestinal Tract”. Cheshire, England, April 10–12, 1983

  18. Robert A. Role of endogenous and exogenous prostaglandins in mucosal protection.In Mechanisms of Mucosal Protection in Upper Gastrointestinal Tract, A Allen, G Flemström, W Silen, LA Turnberg (eds). New York: Raven Press, 1984, pp 377–382

    Google Scholar 

  19. Ruwart MJ, Bush BD, Friedle NM, Stachura J, Tarnawski A: 16, 16-dimethyl-PGE2 protection against L-naphylisothio-cyanate-induced experimental cholangitis in the rat. Hepatology 4:658–660, 1984

    Google Scholar 

  20. Stachura J, Tarnawski A, Ivey KJ, Mach T, Bogdal J, Szczudrawa J, Klimczyk B: Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 81:211–227, 1981

    Google Scholar 

  21. Stachura J, Tarnawski A, Szczudrawa J, Piper RC, Kolaja GJ: Cytoprotective effect of 16,16-dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat. Folia Histochem Cytochem 9:459–474, 1980

    Google Scholar 

  22. Ruwart MJ, Rush BD, Friedle NM, Piper RC, Kolaja GJ: Protective effects of 16,16-dimethyl-PGE2 on the liver and kidney. Prostaglandins 21 (Suppl):97–102, 1981

    Google Scholar 

  23. Papanicolaou N, Callard P, Bariety J, Milliez P: The effect of indomethacin and prostaglandin (PGE2) on renal failure due to glycerol in saline-loaded rats. Clin Sci Molec Med 49:507–510, 1975

    Google Scholar 

  24. Martin DM, Someren AO, Nasrallah SM: The effect of prostaglandin E2 on ethionine-induced pancreatitis in the rat. Gastroenterology 81:736–741, 1981

    Google Scholar 

  25. Manabe T, Steer ML: Protective effect of PGE2 on dietinduced pancreatitis in mice. Gastroenterology 78:777–781, 1980

    Google Scholar 

  26. Coelle EF, Adham N, Elashoff J, Lewin K, Taylor IL: Effects of prostaglandin and indomethacin on diet-induced pancreatitis in mice. Gastroenterology 85:1307–1312, 1983

    Google Scholar 

  27. Raskin DJ, Gray K: Cytoprotection of the urinary bladder with 16,16-dimethyl prostaglandin E2 during cyclophosphamide therapy. Cancer Ass Proc 25:351 (Abstract), 1984

    Google Scholar 

  28. Ruppin H, Person B, Domschke W, Robert A: Zytoprotektive Wirkungen von Prostaglandin E2 auf die Magenschleimhaut bein Menschen. Deutsche Medizinische Wochenschrift 104:1457–1458, 1979

    Google Scholar 

  29. Tarnawski A, Stachura J, Ivey KJ, Mach T, Klimczyk B, Bogdal J: Protection by prostaglandin against ethanol-induced gastric mucosal damage in man. An endoscopic and histologic assessment. Gastroenterology 80:1300 (Abstract), 1981

    Google Scholar 

  30. Tarnawski A, Stachura J, Klimczyk B, Mach T, Ivey KJ: Endoscopic appearance, trans-endoscopic potential difference, pH, histologic and ultra structural changes in human gastric mucosa after alcohol. Gastrointest Endosc 28:145 (Abstract), 1982

    Google Scholar 

  31. Gurll NJ, Harmon JW, Reynolds DG: Histamine H1 and H2 receptor blockade does not maintain electrochemical gradients across canine gastric mucosa exposed to bile salt. Dig Dis Sci 27:538–544, 1982

    Google Scholar 

  32. Müller-Lissner St. A, Fimmel CH, Blum AL: Failure of 16,16-dimethyl PGE2 to protect the human stomach from taurocholate induced damage. Hepatogastroenterologica 30: 107–112, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Clinical Research, G. D. Searle and Company Inc., 4901 Searle Parkway, 60077, Skokie, Illinois

    Esam Z. Dajani PhD, FACG & Catherine H. Nissen BA

Authors
  1. Esam Z. Dajani PhD, FACG
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catherine H. Nissen BA
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dajani, E.Z., Nissen, C.H. Gastrointestinal cytoprotective effects of misoprostol. Digest Dis Sci 30 (Suppl 11), 194S–200S (1985). https://doi.org/10.1007/BF01309408

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01309408

Keywords

Search

Navigation